Top Markets
Coin of the day
Taysha Gene Therapies, Inc. Taysha Gene Therapies, Inc.

Taysha Gene Therapies, Inc.

TSHA
Peringkat dalam Saham #6652
Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and... Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and market introduction of gene therapies that utilize adeno-associated virus (AAV) vectors. Its core mission is to tackle inherited diseases affecting the central nervous system (CNS). The company's development pipeline features several key programs: TSHA-120 is aimed at giant axonal neuropathy; TSHA-102 is in development for Rett syndrome; TSHA-121 and TSHA-118 are both being advanced for CLN1 disease; TSHA-105 addresses SLC13A5 Deficiency; and TSHA-101 targets GM2 gangliosidosis. Furthermore, Taysha has forged a strategic alliance with The University of Texas Southwestern Medical Center to jointly advance and bring to market innovative gene therapy solutions. Founded in 2019, the company operates from its headquarters in Dallas, Texas.
Harga Saham
$6.02
Terakhir disinkronkan: 2026-08-27
Kapitalisasi Pasar
$1.93B
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
112.72%
Negara
US
Perdagangan Taysha Gene Therapies, Inc. (TSHA)

Kategori

Riwayat pemecahan saham untuk Taysha Gene Therapies, Inc. (TSHA)
Saham Taysha Gene Therapies, Inc. (simbol: TSHA) telah mengalami total 0 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Aug 28, 2026.
Satu lembar saham TSHA yang dibeli sebelum Aug 28, 2026 sekarang setara dengan 0 lembar saham TSHA.
Daftar pemecahan saham
Tahun Pemecahan Kelipatan Kelipatan Kumulatif
Tidak cukup data untuk tanggal yang disediakan.
Pemecahan saham untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pemecahan saham Kelipatan Kumulatif Negara
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH